Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-01-19-Speech-3-218-500"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110119.20.3-218-500"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"During previous parliamentary committee debates, it has often been repeated that this directive is not intended to encourage ‘healthcare tourism’, but just to establish clear rules on cross-border healthcare.
It is important for medical treatment received in a Member State other than a patient’s Member State of affiliation to be based on a proven, objective need, in order to avoid burdening national health systems with excessive costs which would inevitably compromise their efficiency. A step forward has been taken with regard to rare diseases: patients will find it easier to access highly specialised treatment and will have the option of asking to see a specialist in another Member State.
I therefore believe that the establishment of national contact points to ensure that patients are fully informed about treatment available in other countries and about how to access and be reimbursed for cross-border treatment is important. Finally, I would like to emphasise that Member States’ exclusive jurisdiction over available treatments and ethical choices in the field of health should not, under any circumstances, be called into question."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples